Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Celsion Corp (CLSN)

Celsion Corp (CLSN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 114,288
  • Shares Outstanding, K 31,924
  • Annual Sales, $ 500 K
  • Annual Income, $ -16,850 K
  • 60-Month Beta 2.48
  • Price/Sales 234.96
  • Price/Cash Flow N/A
  • Price/Book 6.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.15
  • Number of Estimates 3
  • High Estimate -0.10
  • Low Estimate -0.22
  • Prior Year -0.29
  • Growth Rate Est. (year over year) +48.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.93 +22.18%
on 06/11/20
6.50 -44.92%
on 06/17/20
+0.25 (+7.51%)
since 06/10/20
3-Month
0.97 +269.07%
on 04/13/20
6.50 -44.92%
on 06/17/20
+2.59 (+260.67%)
since 04/09/20
52-Week
0.69 +421.49%
on 03/18/20
6.50 -44.92%
on 06/17/20
+1.79 (+100.00%)
since 07/10/19

Most Recent Stories

More News
Global Liver Cancer Therapeutics Market By Cancer Type, By Therapy, By Equipment, By Age, By Factors, By Route of Administration, By Region, Forecast & Opportunities, 2025

, /PRNewswire/ --Read the full report: As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model....

ARQL : 20.00 (+0.15%)
BAYRY : 17.9800 (+0.45%)
BMY : 57.43 (-1.17%)
CLSN : 3.58 (-2.72%)
ESALF : 80.0100 (+1.28%)
EXEL : 24.94 (+3.14%)
MRK : 76.73 (+0.05%)
NVS : 87.01 (-0.38%)
PFE : 33.83 (+1.11%)
Celsion Affirms July Timing for Second Interim Analysis of the Phase III OPTIMA Study of ThermoDox(R) in Primary Liver Cancer

Celsion Corporation (NASDAQ: CLSN), an oncology drug-development company, today affirmed that the independent Data Monitoring Committee (iDMC) is scheduled to meet during the first half of July to conduct...

CLSN : 3.58 (-2.72%)
Celsion Corporation Announces Closing of Public Offering of Common Stock

Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced the closing of its previously announced public offering of 2,666,667 shares of common stock, resulting in net proceeds...

CLSN : 3.58 (-2.72%)
Celsion Corporation Announces Pricing of $10 Million Underwritten Offering of Common Stock

Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced the entry into an underwriting agreement relating to the sale of 2,666,667 shares of its common stock at an offering...

CLSN : 3.58 (-2.72%)
Thinking about buying stock in Celsion Corp, Alkaline Water Company, Salem Media Group, Ocular Therapeutix, or Delta Air Lines?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLSN, WTER, SALM, OCUL, and DAL.

WTERD : 0.6500 (-7.14%)
CLSN : 3.58 (-2.72%)
DAL : 27.09 (+5.61%)
Implied Volatility Surging for Celsion (CLSN) Stock Options

Investors need to pay close attention to Celsion (CLSN) stock based on the movements in the options market lately.

CLSN : 3.58 (-2.72%)
Thinking about buying stock in Ovid Therapeutics, Celsion Corp, Aileron Therapeutics, Cronos Group, or Bank of America?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OVID, CLSN, ALRN, CRON, and BAC.

ALRN : 1.0700 (-4.46%)
BAC : 24.02 (+5.49%)
CLSN : 3.58 (-2.72%)
OVID : 7.47 (-4.35%)
Celsion Reports Data Safety Monitoring Board Recommendation to Proceed to Phase II of the OVATION 2 Study in Advanced Ovarian Cancer

Excellent Surgical Response Noted at the Higher, 100 mg/mDose

CLSN : 3.58 (-2.72%)
Why Small-Cap ETFs & Stocks Outperformed Last Week

Given the improvements in domestic economy, small-cap stocks led the way higher last week.

CLSN : 3.58 (-2.72%)
RENN : 3.73 (+1.77%)
NAVB : 4.05 (+1.00%)
FYT : 29.41 (+3.21%)
PSCM : 37.29 (-0.70%)
PSCE : 3.29 (+2.40%)
PSCI : 57.33 (+2.99%)
SQLV : 21.23 (-2.51%)
OMP : 7.60 (+3.40%)
CVSI : 0.6100 (+8.91%)
Celsion Corporation Reports First Quarter 2020 Financial Results and Provides Business Update

Phase III OPTIMA Study on Track for Interim Data Analysis in July

CLSN : 3.58 (-2.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CLSN with:

Business Summary

Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the...

See More

Key Turning Points

2nd Resistance Point 3.75
1st Resistance Point 3.66
Last Price 3.58
1st Support Level 3.51
2nd Support Level 3.45

See More

52-Week High 6.50
Fibonacci 61.8% 4.28
Fibonacci 50% 3.59
Last Price 3.58
Fibonacci 38.2% 2.91
52-Week Low 0.69

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar